Search results
28 sie 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL multi-dose vial (3 doses per vial) presentation).
11 gru 2020 · COMIRNATY ® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech. It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older; It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:
25 cze 2022 · COMIRNATY® (COVID-19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older. COMIRNATY® is administered as a 2-dose primary series.
11 wrz 2023 · Individuals who have received one dose of any Pfizer BioNTech COVID-19 Vaccine, including Pfizer-BioNTech COVID-19 Vaccine, Bivalent: Two doses of Pfizer-BioNTech COVID-19 Vaccine (2023-2024...
19 kwi 2024 · Quick Summary. Vaccine name: BNT162b2, marketed as Comirnaty. Design type: mRNA. Population: Adults and children 12 years of age and older. Dose number: Originally 2, 21 days apart, with a...
22 sie 2024 · Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single)...
22 sie 2024 · The information in this Fact Sheet about the Pfizer-BioNTech COVID-19 Vaccine, including information about the benefits, risks, and ingredients of that vaccine, also applies to your...
